Biogen (BIIB) Stock Valuation: P/E Ratio and Intrinsic Value

Is Biogen stock expensive or cheap? This page shows the price-earnings ratio of Biogen for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings.

How the Biogen P/E ratio is calculated

The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Biogen is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.

Frequently asked questions about Biogen

What is the BIIB P/E ratio?

The P/E ratio divides the Biogen share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of BIIB can be compared with its own history.

Is Biogen stock overvalued or undervalued?

There is no single answer. A useful check is whether the current P/E of BIIB is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.

How can I estimate the intrinsic value of Biogen?

An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of BIIB as the starting point.

More on Biogen

• Biogen stock: revenue, segments and business model
• Biogen quarterly earnings